Search Results - "Tonui, Willy K."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Immunization with Leishmania major Exogenous Antigens Protects Susceptible BALB/c Mice against Challenge Infection with L. major by TONUI, Willy K, MEJIA, J. Santiago, HOCHBERG, Lisa, MBOW, M. Lamine, RYAN, Jeffrey R, CHAN, Adeline S. T, MARTIN, Samuel K, TITUS, Richard G

    Published in Infection and Immunity (01-10-2004)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    A Cross-Sectional Survey of Biosafety Professionals Regarding Genetically Modified Insects by O’Brochta, David A., Tonui, Willy K., Dass, Brinda, James, Stephanie

    Published in Applied biosafety (01-03-2020)
    “…Background: Genetic technologies such as gene editing and gene drive create challenges for existing frameworks used to assess risk and make regulatory…”
    Get full text
    Journal Article
  3. 3

    Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya by Kigondu, Elizabeth V.M., Rukunga, Geoffrey M., Keriko, Joseph M., Tonui, Willy K., Gathirwa, Jeremiah W., Kirira, Peter G., Irungu, Beatrice, Ingonga, Johnstone M., Ndiege, Isaiah O.

    Published in Journal of ethnopharmacology (25-06-2009)
    “…Indigenous rural communities in the tropics manage parasitic diseases, like malaria and leishmaniasis, using herbal drugs. The efficacy, dosage, safety and…”
    Get full text
    Journal Article
  4. 4

    Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice by Tonui, Willy K, Titus, Richard G

    “…Vaccinating with soluble Leishmania major promastigote exogenous antigens (LmSEAgs) protects mice against challenge with L. major. To explore the potential of…”
    Get more information
    Journal Article
  5. 5

    Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania by Al-Wabel, Mohammad A, Tonui, Willy K, Cui, Liwang, Martin, Samuel K, Titus, Richard G

    “…Leishmania major culture-derived, soluble, exogenous antigens have been shown to be a source of vaccine targets for the parasite. We have previously reported…”
    Get more information
    Journal Article
  6. 6
  7. 7

    LEISHMANIA MAJOR SOLUBLE EXO-ANTIGENS (LmSEAgs) PROTECT NEONATAL BALB/C MICE FROM A SUBSEQUENT CHALLENGE WITH L. MAJOR AND STIMULATE CYTOKINE PRODUCTION BY LEISHMANIA-NAÏVE HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS by Tonui, Willy K, Titus, Richard G

    Published in The Journal of parasitology (01-10-2006)
    “…The vaccine potential and immunogenicity of soluble Leishmania major exo-antigens (LmSEAgs), a potentially novel source for vaccine candidates for…”
    Get full text
    Journal Article
  8. 8
  9. 9